HighPoint Clinical Trials Center

High Point, North Carolina 27265

0 studies enrolling now · 40 studies all time

What they study most

Complement Mediated Diseases, Diabetes Mellitus, Type 2, Electronic Cigarette Use, End Stage Renal Disease, Gout, Hyperuricemia, Healthy, Homocystinuria, Hyperlipidemia, Hypertension, Hypoglycemia, Migraine, Mild Alzheimer's Disease

Studies at this site

• CSD201203: A Study to Determine Subject Puffing Patterns of a Non-cylindrical, Closed, Electronic Nicotine Delivery System at Three Nicotine Concentrations in an Ambulatory Setting — Completed
• Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products — Completed
• Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days — Completed
• Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users — Completed
• A Study of Mirikizumab in Participants With Plaque Psoriasis — Completed
• Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus — Completed
• Sublingual vs IV Atropine Bioavailability Study — Completed
• CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function — Completed
• Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers — Completed
• BAT3221032: A Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects — Completed
• CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting — Completed
• CSD1601: A Study to Evaluate the Exposure to Tar and Nicotine From Two Cigarette Products That Contain a Menthol Capsule in the Filter — Completed
• CSD201202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System P12 — Completed
• Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy — Completed
• Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers — Completed
• Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients — Completed
• A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD — Completed
• A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes — Completed
• Insulin Tolerance Test Study in Patients With Type 1 Diabetes — Stopped early
• A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM — Completed
• CSD1805: Study to Assess Nicotine Uptake and Product Use Behavior in Moist Snuff Consumers Using Two Moist Snuff Products — Completed
• A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. — Completed
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• A Study Comparing User Experience of Different Delivery Devices for Glucagon — Completed
• 2-Week Study In People With Nonalcoholic Fatty Liver Disease — Completed
• CSD190301: A Study to Assess Elements of Abuse Liability for Two Dissolvable Nicotine Lozenge Tobacco Products — Completed
• Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants — Completed
• CSD190102: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products — Completed
• CSD190103: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products — Completed
• CSD190101: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products — Completed
• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol — Stopped early
• A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy — Completed
• A Study of Ixekizumab in Participants With Plaque Psoriasis — Completed
• A Study of LY3209590 in Participants With Type 2 Diabetes — Completed
• 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension — Completed
• CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes — Completed
• First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers — Completed
• Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus. — Completed
• Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease — Stopped early